Table 2. Univariate analysis of OS.
| Characteristic Age (years) | Cases | Median Survival (months) | 95% (CI) (months) | P-value |
|---|---|---|---|---|
| < 60 | 19 | 5.0 ± 0.6 | 3.6–6.5 | P = 0.645 |
| > = 60 | 26 | 6.0 ± 0.5 | 4.9–7.2 | |
| Gender | ||||
| Male | 20 | 5.0 ± 0.7 | 3.5–6.8 | P = 0.263 |
| Female | 25 | 6.0 ± 0.5 | 5.0–7.0 | |
| Differentiation | ||||
| Poorly | 28 | 5.0 ± 0.7 | 3.5–6.5 | P = 0.328 |
| Medium and high | 17 | 8.0 ± 0.5 | 1.8–15.2 | |
| Treatment | ||||
| Chemical treatment | 25 | 6.0 ± 0.8 | 4.0–8.2 | P = 0.048 |
| None | 20 | 4.0 ± 0.4 | 2.7–5.6 | |
| YAP expression | ||||
| High and moderate | 37 | 4.0 ± 0.6 | 3.1–5.1 | P = 0.015 |
| low and none | 8 | 7.0 ± 0.6 | 5.4–8.2 |
Abbreviations: CI, confidence interval.
low YAP expression and chemotherapy treatment were positively correlated with the patients’ survival (p = 0.015 and p = 0.048).